Clinical Research Directory
Browse clinical research sites, groups, and studies.
to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection
Sponsor: Daewoong Pharmaceutical Co. LTD.
Summary
to evaluate the safety/tolerability and pharmacokinetics, and pharmacodynamics after intravenous DWP14012 injection in healthy participants
Official title: A Randomized, Double-blind, Placebo-controlled, Single/Multiple-dose, Phase 1 Clinical Trial to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics After Intravenous DWP14012 Injection in Healthy Participants
Key Details
Gender
All
Age Range
19 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2024-07
Completion Date
2025-05
Last Updated
2024-06-03
Healthy Volunteers
Yes
Conditions
Interventions
Fexuprazan Injection
20/40/80 mg
Fexuprazan Injection placebo
20/40/80 mg
Fexuprazan Injection_part 2
20mg
Fexuprazan Injection_part 3
40mg
Fexuprazan tablet
40mg